Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for smoking cessation in alcoholics
NCT00044434Phase 4Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- May 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Bupropion + NRT with Placebo + NRT (2 arms). Primary endpoint: Smoking cessation rate at 6 months. Started May 2002; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00044434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044434.